Abstract
The main goal of this project is to characterize the optimal hiPSC-derived cell population for cardiac regeneration after MI, using a preclinical model of Ml in pigs. First, human iPSCs will be generated from either human fibroblasts or urine samples using a non-integrative reprogramming strategy based on episomal transfection. hiPSCs will be characterized to ensure they show the typical …